GBAF Logo
Global Banking & Finance Awards® 2026 Nominations open, free to enter Nominate now →
L

Ligand Pharmaceuticals LGND · USD

Health Care · US listing · 🇺🇸 United States

Compare

314.15

+2.60%

Close of 9 Nov 2026, in USD

Search any instrument

Reference data, closing prices and charts across 45,000 companies, plus crypto, commodities and currencies.

Latest on Ligand Pharmaceuticals

Our reporting

Next results

25 Feb 2027

Due on 25 Feb 2027. Analysts expect earnings of 2.87 a share on revenue of $97.0m.

Past results

Reported against what analysts expected

29 Oct 20266 Aug 202614 May 20267 May 202626 Feb 20266 Nov 2025
Earnings per share2.672.371.63-0.672.023.09
Forecast2.332.011.840.981.461.97
Revenue$78.7m$63.7m$51.7m—$59.7m$115.5m
Forecast$77.0m$61.3m$59.1m—$55.6m$58.7m

Key events

  1. 19 Nov 20106-to-1 reverse split
  2. 18 Nov 1992Listed

Ligand Pharmaceuticals in the news

Headlines from other publishers, linked to their own pages.

Sources and methodology

Data on this tab
Our reporting and our data supplier
Chart on the Overview
TradingView

Nothing here is investment advice. Prices can be delayed or wrong, so check with the exchange before relying on them. Data for this page. How we cover markets.